- Market Realist•10 minutes ago
For 2016, Merck & Co. (MRK) reported revenue close to $39.8 billion, a year-over-year (or YoY) rise of ~1%. New product launches have played major roles in boosting Merck’s 2016 revenue.
- Reuters•1 hour ago
Johnson & Johnson on Monday said the average list price of its drugs rose less than 10 percent each year since 2012, noting that the net price paid for the drugs, which includes discounts and rebates, was significantly lower. The company released a report with its price increase history in response to widespread outcry over high U.S. prices for prescription drugs. U.S. President Donald Trump has said drug companies are "getting away with murder" in what they charge the government for medicines.
- Investopedia•2 hours ago
Cempra’s bacterial-skin infection pill did well in a late-study clinical trial.
MRK : Summary for Merck & Company, Inc. Common St - Yahoo Finance
Merck & Co., Inc. (MRK)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||65.56 - 65.94|
|52 Week Range||50.09 - 66.16|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||32.28|
|Dividend & Yield||1.88 (2.84%)|
|1y Target Est||N/A|